Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago
Open Access
- 16 November 2021
- journal article
- case report
- Published by Wiley in Clinical Case Reports
- Vol. 9 (11) , e05075
Abstract
A 72‐year‐old female patient used the oral phosphate binder lanthanum carbonate for 6 years, before discontinuing it after receiving a pancreas and kidney transplant. Now, 7 years after discontinuation, the patient developed bilious emesis. An upper gastrointestinal endoscopy showed an unspecific gastritis. Biopsies showed subepithelial crystalline deposits consistent with gastric lanthanosis.Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- A Nodular Foreign Body Reaction in a Dialysis Patient Receiving Long-term Treatment With Lanthanum CarbonateAmerican Journal of Kidney Diseases, 2016
- Lanthanum Deposition Is Frequently Observed in the Gastric Mucosa of Dialysis Patients With Lanthanum Carbonate TherapyInternational Journal of Surgical Pathology, 2015
- Possibility of lanthanum absorption in the stomachClinical Kidney Journal, 2015
- Peculiar Histiocytic Lesions With Massive Lanthanum Deposition in Dialysis Patients Treated With Lanthanum CarbonateAmerican Journal of Surgical Pathology, 2015
- Lanthanum-Induced Gastrointestinal HistiocytosisACG Case Reports Journal, 2015
- Investigation of deposition of lanthanum on gastric mucosa in hemodialysis patients with lanthanum therapyNihon Toseki Igakkai Zasshi, 2015
- Extensive lanthanum deposition in the gastric mucosa: The first histopathological reportPathology International, 2014
- Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight JunctionAmerican Journal of Nephrology, 2013
- Clinical Pharmacokinetics of the Phosphate Binder Lanthanum CarbonateClinical Pharmacokinetics, 2008
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994